Literature DB >> 6319502

Visualization of epidermal growth factor receptors in human epidermis.

L B Nanney, J A McKanna, C M Stoscheck, G Carpenter, L E King.   

Abstract

The localization of epidermal growth factor (EGF) receptors in normal human epidermis was examined with two independent experimental methods. The distribution of EGF receptor sites was studied using light microscopic autoradiography with [125I]EGF and direct immunocytochemical techniques with EGF receptor antibodies and protein A-colloidal gold complexes. Direct visualization by autoradiography indicated that the concentration of EGF receptors was greatest in the lower epidermal layers. Ultrastructural morphometric analysis of protein A-gold complexes showed that EGF receptors were primarily associated with the plasma membranes although intranuclear and cytoplasmic localization was also evident. This postembedment immunolocalization method also confirmed the relative differences in the number of EGF receptors found in individual epidermal layers (basalis greater than spinosum greater than granulosum greater than corneum layers). This inverse relationship between numbers of EGF receptors and the degree of epidermal differentiation and/or keratinization may suggest a physiologic role for EGF in these processes in human epidermis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319502     DOI: 10.1111/1523-1747.ep12259731

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  19 in total

1.  Automatic determination of labeling density in protein A-gold immunocytochemical preparations using an image analyzer. Application to peroxisomal enzymes.

Authors:  K Beier; H D Fahimi
Journal:  Histochemistry       Date:  1985

Review 2.  The Roles of Growth Factors in Keratinocyte Migration.

Authors:  Mark A Seeger; Amy S Paller
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-04-01       Impact factor: 4.730

3.  Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin.

Authors:  A P Lavrijsen; L M Tieben; M Ponec; J G van der Schroeff; G N van Muijen
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  Epidermal growth factor and transferrin receptor expression in human embryonic and fetal epidermal cells.

Authors:  G Zambruno; G Girolomoni; V Manca; A Segre; A Giannetti
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

5.  Epidermal growth factor (EGF)-induced morphological changes in the basement membrane of chick embryonic skin. An electron-microscopic study.

Authors:  Y Akimoto; A Obinata; H Endo; H Hirano
Journal:  Cell Tissue Res       Date:  1988       Impact factor: 5.249

6.  Effects of epidermal growth factor and transforming growth factor alpha on the function of wool follicles in culture.

Authors:  J J Bond; P C Wynn; G P Moore
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

7.  The level of urinary epidermal growth factor is not influenced by the extent of psoriatic lesions.

Authors:  S Kondo; N Sato; K Aso
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

8.  Localization of human epidermal growth factor receptor in cervical intraepithelial neoplasias.

Authors:  A Göppinger; F M Wittmaack; H O Wintzer; H Ikenberg; T Bauknecht
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

9.  Cultivation of mesenchymal cells derived from the skin and hair follicles of the sheep: the involvement of peptide factors in growth regulation.

Authors:  P Pisansarakit; D L du Cros; G P Moore
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

10.  Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis.

Authors:  S M Snedeker; C F Brown; R P DiAugustine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.